United Kingdom · 
What does Apposite Capital invest in?
Apposite Capital invests most often at Series A and Series D (67% of the rounds on record), in sectors such as Industrial IoT, Advanced Manufacturing and Drugs.
Apposite Capital highlights
- 01
9 rounds on record
- 02
Mostly Series A and Series D: 67% of its rounds
- 03
3 exits from the portfolio
What they do
experienced private equity investors dedicated to the UK and European healthcare industryFrom their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $5.0M – $25M as they say
- Stages
- Series ASeries BGrowth
- Sectors
- Industrial IoTAdvanced ManufacturingDrugs
- Based in
- London, United Kingdom
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first9 appearances
- 2014
1 round
- Mar
- 2012
1 round
- Nov
- 2011
2 rounds
- Jun
- Feb
- 2010
1 round
- Oct
- 2009
1 round
- Jun
- 2008
1 round
- Aug
- 2007
2 rounds
- Nov
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 29 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
1 of 2 we have independently watched raise
Cloudflare TurnstileDesign by WildWest
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed3 in all
Convergence PharmaceuticalsBought by Biogen Idec$675MJan 2015
Ambit BiosciencesBought by Daiichi Sankyo$410MSept 2014
UltheraBought by Merz$600MJun 2014
An exit counts when it came after the firm's first round in the company. From historical deal records.